Baltimore Orioles outfielder Heston Kjerstad has been handed an 80-game suspension after testing positive for a banned substance, violating Major League Baseball’s performance-enhancing drug (PED) policy. The league announced the suspension on [insert date], revealing that Kjerstad’s test detected [specific substance if available], a substance prohibited under the MLB’s Joint Drug Prevention and Treatment Program.
Kjerstad, a highly regarded young talent within the Orioles organization, was expected to play a significant role for the team this season. The suspension is a major setback for both the player and the franchise, as it sidelines the 25-year-old for half of the regular season, limiting his opportunity to contribute. The Orioles, who have been building a strong roster with aspirations of making a deep postseason run, will now have to adjust their lineup and depth chart accordingly.
Kjerstad has yet to release a public statement regarding the suspension, but players in similar situations have often appealed or issued apologies. The Orioles organization has acknowledged the situation but has not provided detailed comments beyond confirming the league’s decision.
Drafted second overall by Baltimore in 2020, Kjerstad overcame early career challenges, including health concerns, to emerge as a promising outfielder. His power-hitting ability and potential made him a key figure in the team’s plans moving forward. With this suspension, however, his reputation takes a hit, and he will have to regain trust and prove himself once eligible to return to the field.
The Orioles will now look to their depth options to fill the void left by Kjerstad’s absence as they navigate the early part of the season without one of their top young hitters.
